>
>
Artemisinin Antimalarial Drugs Market - By Malaria Type (Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Ovale, Plasmodium Malariae, Plasmodium Knowlesi), Product (Injections, Tablets), Type (Combination, Monotherapy & Forecast, (2024 – 2032)
Download Free PDF

Artemisinin Antimalarial Drugs Market
Get a free sample of this reportGet a free sample of this report Artemisinin Antimalarial Drugs Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 10
Tables & Figures: 182
Countries covered: 22
Pages: 102
Download Free PDF
Artemisinin Antimalarial Drugs Market Size
Artemisinin Antimalarial Drugs Market was valued at USD 672.2 million in 2023 and is anticipated to grow at a CAGR of 4.2% between 2024 – 2032. The rising incidence of malaria, particularly in tropical and subtropical regions, has increased the demand for effective treatments.
For instance, as per the CDC, in 2022, an estimated 249 million malaria cases occurred globally, leading to 608,000 malaria deaths in a single year. Such high incidence of malaria cases increases the demand for effective treatments, thereby driving the growth of artemisinin antimalarial drugs market.
Additionally, the emergence of artemisinin-based combination therapies (ACTs) as a gold standard for malaria treatment has significantly contributed to market expansion. Moreover, ongoing research and development efforts aimed at enhancing the efficacy and safety profiles of these drugs coupled with advancements in malaria diagnostics further boost market growth. The global focus on malaria eradication and the support from international organizations, including the World Health Organization, in funding and promoting antimalarial programs also play a crucial role. Furthermore, the growing awareness about the importance of early diagnosis and treatment of malaria supports the demand for artemisinin-based therapies, driving the market forward.
Artemisinin antimalarial drugs are a class of medications derived from the plant Artemisia Annua, commonly known as sweet wormwood. These drugs are primarily used to treat malaria, particularly in cases caused by Plasmodium falciparum. Artemisinin-based treatments are known for their rapid action in reducing parasite load and alleviating symptoms. The most common form of these treatments are artemisinin-based combination therapies (ACTs), which combine artemisinin derivatives with other antimalarial drugs to enhance efficacy and reduce the risk of drug resistance.
Artemisinin Antimalarial Drugs Market Trends
Artemisinin Antimalarial Drugs Market Analysis
Based on the malaria type, the artemisinin antimalarial drugs industry is categorized into Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi. The Plasmodium falciparum segment dominated the market with USD 553.8 million in 2023.
Based on product, the artemisinin antimalarial drugs market is segmented into antimalarial injections and antimalarial tablets. The antimalarial tablets segment is dominated the market holding the highest market share of 80.5% in 2023.
Based on the type, the artemisinin antimalarial drugs market is segmented into monotherapy and combination therapy. The combination therapy segment is projected to reach USD 660.7 million by 2032.
Middle East & Africa market was valued at USD 231.5 million in 2023 and is expected to witness growth at a CAGR of 4.1% between 2024 – 2032.
Asia Pacific region accounted for the second largest share of 26.7% in 2023.
Latin American region presents significant growth potential in the artemisinin antimalarial drugs market due to a combination of factors.
Artemisinin Antimalarial Drugs Market Share
The competitive landscape of the artemisinin antimalarial drugs industry is characterized by a diverse mix of pharmaceutical companies and research institutions striving to innovate and expand their market presence. Key players in this sector include pharmaceutical giants like Novartis and Sanofi, which have established themselves as leading suppliers of artemisinin-based combination therapies (ACTs). These companies leverage their extensive distribution networks and substantial R&D investments to maintain a competitive edge.
Additionally, smaller biotech firms and emerging players are actively involved in developing new formulations and improving the efficacy of existing treatments. Strategic collaborations, partnerships, and ongoing research into novel drug combinations and delivery methods are pivotal in shaping the competitive dynamics and driving advancements in the market.
Artemisinin Antimalarial Drugs Market Companies
Few of the prominent players operating in industry include:
Artemisinin Antimalarial Drugs Industry News:
The artemisinin antimalarial drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Malaria Type
Market, By Product
Market, By Type
The above information is provided for the following regions and countries: